Open AccessTo evaluate the efficacy and safety profile of rosuvastatin, simvastatin and atorvastatin in newly diagnosed type 2 diabetic patients with dyslipidaemia
Author(s) -
Pravin Dhone,
Rahul Gulati,
Padmini Sahu,
Mohd. Faheem Mubeen,
Mohd. Faheem Mubeen
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns6.10585
Subject(s) - medicine , dyslipidemia , atorvastatin , type 2 diabetes mellitus , simvastatin , group b , gastroenterology , group a , diabetes mellitus , rosuvastatin , type 2 diabetes , insulin resistance , lipid profile , endocrinology , insulin , obesity , cholesterol